Description

Acetamide, n-[(2-Chloro-6-Methoxy-3-Quinolinyl)Methyl]-n-Cyclopentyl- (9Ci) is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of complex active pharmaceutical ingredients (APIs). This compound is critical for research and development in medicinal chemistry, offering a precise molecular scaffold for creating novel therapeutic agents. It is primarily utilized by pharmaceutical manufacturers and contract research organizations (CROs) focused on developing new drug candidates, particularly in oncology and other specialized therapeutic areas.

Application

• Pharmaceutical Intermediate: A key building block in the multi-step synthesis of novel quinoline-based drug candidates.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies to develop new therapeutic molecules.
• API Development: Serves as a critical precursor in the production of active pharmaceutical ingredients for preclinical and clinical trials.
• Oncology Drug Discovery: Employed in the research and development of targeted cancer therapies due to its quinoline core structure.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects.
• Academic Research: Used in university and institutional labs for chemical biology and drug discovery programs.

Basic Information

Product Name	Acetamide, n-[(2-Chloro-6-Methoxy-3-Quinolinyl)Methyl]-n-Cyclopentyl- (9Ci)
CAS No.	606102-59-4
Molecular Formula	C18H21ClN2O2
Molecular Weight	332.83 g/mol
Synonyms	N-[(2-Chloro-6-methoxyquinolin-3-yl)methyl]-N-cyclopentylacetamide; N-Cyclopentyl-N-[(2-chloro-6-methoxy-3-quinolinyl)methyl]acetamide; Acetamide, N-[(2-chloro-6-methoxy-3-quinolinyl)methyl]-N-cyclopentyl-; 606102-59-4; UNII-8J4N1C5K8H; 8J4N1C5K8H; AOB67717; BDBM50111071; AKOS005147209
EINECS	Contact for details

Quality Control

Every batch of Acetamide, n-[(2-Chloro-6-Methoxy-3-Quinolinyl)Methyl]-n-Cyclopentyl- (9Ci) undergoes rigorous analytical testing to ensure identity, purity, and consistency. Our quality management system is designed to meet the stringent requirements of pharmaceutical development. A comprehensive Certificate of Analysis (COA) detailing purity by HPLC, identification by spectroscopic methods, and impurity profiles is provided with each shipment to support your regulatory and research needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Any individual impurity ≤ 0.5%
Total Impurities	≤ 2.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.